Ghalib Natasha, Pophali Prateek, Chamorro-Pareja Natalia, Jayarangaiah Apoorva, Kumar Abhishek
Internal Medicine, Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, USA.
Hematology/Oncology, Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, USA.
Cureus. 2021 Feb 1;13(2):e13065. doi: 10.7759/cureus.13065.
A high incidence of thromboembolic events and coagulation parameter abnormalities are seen in cases of coronavirus disease 2019 (COVID-19). Both venous and arterial thrombosis, including arterial thrombosis in unusual sites, have been reported in COVID patients in recent literature. Herein, we report a case of a 67-year-old female patient with non-critical COVID-19 disease with an incidental finding of an asymptomatic splenic infarct. In the absence of a cardio-embolic source, we believe this was an arterial thromboembolic event in the splenic circulation. The duration and modality of anticoagulation of inpatient and ambulatory COVID patients remains a dynamic discussion. Our case adds the evidence of a clinically silent arterial thrombotic event in a non-critical COVID-19 patient which further emphasizes the need to address the strategies for diagnosis and management of thrombo-embolism to prevent potentially fatal complications.
2019冠状病毒病(COVID-19)患者中可见血栓栓塞事件和凝血参数异常的高发生率。近期文献报道,COVID患者中既有静脉血栓形成,也有动脉血栓形成,包括发生在不常见部位的动脉血栓形成。在此,我们报告一例67岁女性患者,患有非重症COVID-19疾病,偶然发现无症状脾梗死。在没有心脏栓塞源的情况下,我们认为这是脾循环中的动脉血栓栓塞事件。住院和门诊COVID患者抗凝治疗的持续时间和方式仍是一个动态的讨论话题。我们的病例补充了非重症COVID-19患者发生临床无症状动脉血栓事件的证据,这进一步强调了需要探讨血栓栓塞的诊断和管理策略,以预防潜在的致命并发症。